Olive Oil and Soybean 1 Oil Based Intravenous Lipid Emulsions, Liver Chemistry and Clinical Outcomes
NCT03442361 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 206
Last updated 2018-02-22
Summary
Background: Intravenous lipid emulsions (IVLE) are an essential component of parenteral nutrition (PN). Omega-6 reducing strategies may improve outcomes, including reduced PN associated liver disease.
Objective: The primary objective was to compare serum alkaline phosphatase (ALP), among surgical and medical patients provided with either Intralipid or Clinoleic lipid emulsions.
Design: In this quasi-experimental study the medical records of surgical and medical adult patients were reviewed from 3 Canadian hospitals that received PN with either soybean oil (Intralipid) or predominantly olive oil (Clinoleic) based lipid emulsions for at least 7 consecutive days.
Conditions
- Parenteral Nutrition Associated Liver Disease
Sponsors & Collaborators
-
University of Calgary
lead OTHER
Principal Investigators
-
Maitreyi Raman · University of Calgary
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-07-01
- Primary Completion
- 2015-06-30
- Completion
- 2018-01-10
More Related Trials
-
Cholestasis Prevention: Efficacy of IV Fish Oil
NCT00512629 ·Status: COMPLETED ·Phase: PHASE1
-
Standard Lipid Therapy vs IVFE Minimization for Prevention of PNALD
NCT02357576 ·Status: COMPLETED ·Phase: PHASE3
-
THE IMMUNOLOGICAL EFFECTS AND METABOLIC TOLERANCE OF LIPID INFUSION IN PATIENTS WITH CIRRHOSIS.
NCT02381769 ·Status: COMPLETED ·Phase: NA
-
Omegaven Treatment of Parenteral Nutrition (PN) Induced Liver Injury
NCT01089426 ·Status: COMPLETED ·Phase: NA
-
Evaluation of OMEGAVEN 10%® (n-3 EFA Lipid Emulsion) in Home Parenteral Nutrition-associated Liver Disease
NCT01284049 ·Status: COMPLETED ·Phase: NA
-
SMOF Lipid for Children With Parenteral Nutrition Induced Liver Injury
NCT02412566 ·Status: APPROVED_FOR_MARKETING
-
Intravenous Branched Chain Amino Acids for Hepatic Encephalopathy in ACLF
NCT04238416 ·Status: COMPLETED ·Phase: PHASE1
-
Omegaven® in the Treatment of Parenteral Nutrition (PN) Induced Liver Injury
NCT01845116 ·Status: COMPLETED ·Phase: PHASE2
-
Intravenous Fish Oils in the Treatment of Parenteral Nutrition Liver Injury
NCT02780193 ·Status: APPROVED_FOR_MARKETING
-
Reduction of Neonatal Parenteral Nutrition Associated Cholestasis Through Lipid Emulsions
NCT02633384 ·Status: TERMINATED ·Phase: PHASE4
-
The Effect of Physical Properties of Lipid Emulsions on Gastrointestinal Function
NCT01253005 ·Status: COMPLETED ·Phase: NA
-
Omegaven® as Parenteral Nutrition
NCT02334293 ·Status: UNKNOWN ·Phase: NA
-
Use of Omega 3 Oil Emulsion for Parenteral Nutrition Associated Cholestasis
NCT02148146 ·Status: NO_LONGER_AVAILABLE
-
Evaluation of Omegaven™ Parenteral Nutrition in Patients With Total Parenteral Nutrition (TPN)-Induced Cholestasis
NCT00826020 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized Study of the Use of Intravenous Choline Supplementation in Long Term Total Parenteral Nutrition
NCT00004697 ·Status: COMPLETED ·Phase: NA
-
To Study the Immunomodulating Effects and Safety Profile of ω3 and ω6 PUFA Containing Intravenous Lipid Emulsion in Patients With Acute on Chronic Liver Failure
NCT02691533 ·Status: COMPLETED ·Phase: NA
-
Compassionate Use of IV Fish Oil for Parenteral Nutrition (PN) Liver Injury
NCT01425567 ·Status: APPROVED_FOR_MARKETING
-
Digestion of Biopolymer Based Lipid Emulsions
NCT02865486 ·Status: COMPLETED ·Phase: NA
-
Compassionate Use of Omegaven to Reverse Parenteral Nutrition Induced Cholestasis
NCT01173159 ·Status: COMPLETED ·Phase: NA
-
Expanded Access of Omegaven IV Fat Emulsion to Infants and Children With PNALD
NCT02929303 ·Status: APPROVED_FOR_MARKETING
-
Cholestasis Reversal: Efficacy of IV Fish Oil
NCT00910104 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Compassionate Use of Omegaven® in the Treatment of Parenteral Nutrition Associated Hepatic Injury
NCT01412359 ·Status: APPROVED_FOR_MARKETING
-
Omegaven Protocol:Intermediate Size Patient Population
NCT03561194 ·Status: APPROVED_FOR_MARKETING
-
Intravenous Fat Emulsion Comprised of Fish Oil in the Treatment of Parenteral Nutrition Induced Liver Injury in Infants
NCT02534077 ·Status: APPROVED_FOR_MARKETING
-
Use of Omegaven Fish Oil Emulsion for Parenteral Nutrition Associated Liver Disease in Infants and Children
NCT01194063 ·Status: COMPLETED ·Phase: PHASE3